Tony Davis "The Office for Life Sciences has launched its Blueprint, a 'package of measures that has the potential to transform the UK for the life sciences industry'.
Is it right - does it address your problems?"
- Tony Davis

Comment from Matthew Harte at Protomed Ltd.

As the government is looking to help life science SME's, if should look to encourage the NHS which is the largest consumer of these products to buy from British companies. From my experience, the NHS has bought solely on price and not necessarily on value or whole life costs and does not really consider where the product is supporting UK industry or not.

I also believe that the government needs to push more in new developments and innovations in this area. I accept that there has been movement in this area in the right direction but I feel that there needs to be an easier route to market that simple innovative products can be implemented quickly and effectively across the NHS if it delivers or is expected to deliver either savings or better health outcomes.